The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 737K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

28 articles for JB Baell


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structural Basis for the Selective Binding of Inhibitors to 6-Hydroxymethyl-7,8-dihydropterin Pyrophosphokinase from Staphylococcus aureus and Escherichia coli.EBI
Monash University
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).EBI
Monash University (Parkville Campus)
Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.EBI
Monash University
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL.EBI
Genentech
De-novo designed library of benzoylureas as inhibitors of BCL-XL: synthesis, structural and biochemical characterization.EBI
The Walter and Eliza Hall Institute of Medical Research
Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL.EBI
The Walter and Eliza Hall Institute of Medical Research
Synthesis and biological evaluation of chalcones as inhibitors of the voltage-gated potassium channel Kv1.3.EBI
The Walter and Eliza Hall Institute of Medical Research
Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors.EBI
The Walter and Eliza Hall Institute of Medical Research
Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activity.EBI
The Walter and Eliza Hall Institute of Medical Research
Trypanothione reductase high-throughput screening campaign identifies novel classes of inhibitors with antiparasitic activity.EBI
Monash University (Parkville Campus)
Discovery of novel and potent benzhydryl-tropane trypanocides highly selective for Trypanosoma cruzi.EBI
Institute of Medical Research
Omega-conotoxin GVIA mimetics based on an anthranilamide core: effect of variation in ammonium side chain lengths and incorporation of fluorine.EBI
The University of Queensland
The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists.EBI
Monash University
Drug discovery and optimization based on the co-crystal structure of natural product with target.EBI
Anhui Medical University
Discovery of 2-iminobenzimidazoles as a new class of trypanothione reductase inhibitor by high-throughput screening.EBI
Institute of Medical Research
Development of [EBI
Monash University
A new class of blockers of the voltage-gated potassium channel Kv1.3 via modification of the 4- or 7-position of khellinone.EBI
Institute of Medical Research Biotechnology Centre
A three-residue, continuous binding epitope peptidomimetic of ShK toxin as a Kv1.3 inhibitor.EBI
Institute of Medical Research
Khellinone derivatives as blockers of the voltage-gated potassium channel Kv1.3: synthesis and immunosuppressive activity.EBI
Institute of Medical Research Biotechnology Centre
Discovery of Potent and Fast-Acting Antimalarial Bis-1,2,4-triazines.EBI
University of Melbourne
Synthesis and evaluation of pyridine-derived bedaquiline analogues containing modifications at the A-ring subunit.EBI
Monash University (Parkville Campus)
Design, Synthesis, and Characterization of Cyclic Peptidomimetics of the Inducible Nitric Oxide Synthase Binding Epitope That Disrupt the Protein-Protein Interaction Involving SPRY Domain-Containing Suppressor of Cytokine Signaling Box Protein (SPSB) 2 and Inducible Nitric Oxide Synthase.EBI
Monash University
Discovery of Acylsulfonohydrazide-Derived Inhibitors of the Lysine Acetyltransferase, KAT6A, as Potent Senescence-Inducing Anti-Cancer Agents.EBI
Monash University (Parkville Campus)
Development of Benzenesulfonamide Derivatives as Potent Glutathione Transferase Omega-1 Inhibitors.EBI
Monash University
Discovery of Benzoylsulfonohydrazides as Potent Inhibitors of the Histone Acetyltransferase KAT6A.EBI
Cancer Therapeutics Crc
Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.EBI
Monash University
Reviewing Hit Discovery Literature for Difficult Targets: Glutathione Transferase Omega-1 as an Example.EBI
Monash University
Synthesis and target identification of hymenialdisine analogs.BDB
Genomics Institute of The Novartis Research Foundation